Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone

Transplantation

Volumn 97, Issue 4, 2014, Pages 405-412

  Haneda, Masataka ^a   Owaki, Mami ^a   Kuzuya, Takafumi ^b   Iwasaki, Kenta ^a   Miwa, Yuko ^a   Kobayashi, Takaaki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS SOCIETY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD38 ANTIGEN; CYCLOSPORIN; EVEROLIMUS; IMMUNOGLOBULIN D ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MYCOPHENOLIC ACID; PREDNISOLONE;

ANTIBODY PRODUCTION; ARTICLE; B CELL CULTURE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; PLASMA CELL; PRIORITY JOURNAL;

ANTIGENS, CD19; B-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CYCLOSPORINE; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MYCOPHENOLIC ACID; PLASMA CELLS; PREDNISOLONE; SIROLIMUS; T-LYMPHOCYTES;

EID: 84896732114     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ratner LE, Hadley GA, Hanto DW, et al. Immunology of renal allograft rejection. Arch Pathol Lab Med 1991; 115: 283
2. Vinuesa CG, Linterman MA, Goodnow CC, et al. T cells and follicular dendritic cells in germinal center B-cell formation and selection. Immunol Rev 2010; 237: 72
3. Deenick EK, Ma CS, Brink R, et al. Regulation of T follicular helper cell formation and function by antigen presenting cells. Curr Opin Immunol 2011; 23: 111
4. Jeras M. The role of in vitro alloreactive T-cell functional tests in the selection of HLA matched and mismatched haematopoietic stem cell donors. Transpl Immunol 2002; 10: 205
5. Augustine JJ, Hricik DE. T-cell immune monitoring by the ELISPOT assay for interferon gamma. Clin Chim Acta 2012; 413: 1359
6. Brunet M. Cytokines as predictive biomarkers of alloreactivity. Clin Chim Acta 2012; 413: 1354
7. Drexler HG, Minowada J. History and classification of human leukemia-lymphoma cell lines. Leuk Lymphoma 1998; 31: 305
8. Moser K, Tokoyoda K, Radbruch A, et al. Stromal niches, plasma cell differentiation and survival. Curr Opin Immunol 2006; 18: 265
9. Arpin C, Dechanet J, Van Kooten C, et al. Generation of memory B cells and plasma cells in vitro. Science 1995; 268: 720
10. Agematsu K, Hokibara S, Nagumo H, et al. Plasma cell generation from B-lymphocytes via CD27/CD70 interaction. Leuk Lymphoma 1999; 35: 219
11. Ettinger R, Sims GP, Fairhurst AM, et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 2005; 175: 7867
12. JourdanM, Caraux A,DeVos J, et al. An in vitromodel of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. Blood 2009; 114: 5173
13. Archdeacon P, Chan M, Neuland C, et al. Summary of FDA antibodymediated rejection workshop. Am J Transplant 2011; 11: 896
14. Heidt S, Roelen DL, Eijsink C, et al. Effects of immunosuppressive drugs on purified human B cells: Evidence supporting the use of MMF and rapamycin. Transplantation 2008: 86: 1292
15. Karnell JL, Karnell FG 3rd, Stephens GL, et al. Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation. J Immunol 2011; 187: 3603
16. Nagai M, Natsumeda Y, Weber G. Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells. Cancer Res 1992; 52: 258
17. Carr SF, Papp E, Wu JC, et al. Characterization of human type I and type II IMP dehydrogenases. J Biol Chem 1993; 268: 27286
18. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000; 47: 85
19. Allison AC, Eugui EM. The design and development of an immunosuppressive drug,mycophenolatemofetil. Springer Semin Immunopathol 1993; 14: 353
20. Heinschink A, Raab M, Daxecker H, et al. In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes. Clin Chim Acta 2000; 300: 23
21. Aagaard-Tillery KM, Jelinek DF. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin. Cell Immunol 1994; 156: 493
22. Matz M, Lehnert M, Lorkowski C, et al. Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation. Transpl Int 2012; 10: 1106
23. Garcýa De Vinuesa C, O'Leary P, Sze DM, et al. T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur J Immunol 1999; 29: 1314
24. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149: 274
25. Miyasaka M, Tanaka T. Lymphocyte trafficking across high endothelial venules: Dogmas and enigmas. Nat Rev Immunol 2004; 4: 360
26. Bohnhorst JØ, Bjørgan MB, Thoen JE, et al. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. J Immunol 2001; 167: 3610
27. Aiba Y, Kometani K, Hamadate M, et al. Preferential localization of IgG memory B cells adjacent to contracted germinal centers. Proc Natl Acad Sci U S A 2010; 107: 12192
28. Kurata Y, Kato M, Kuzuya T, et al. Pretransplant pharmacodynamic analysis of immunosuppressive agents using CFSE-based T-cell proliferation assay. Clin Pharmacol Ther 2009; 86: 285
29. Heidt S, Roelen DL, Eijsink C, et al. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clin Exp Immunol 2010; 159: 199